TabletsTablets
Schedule H (Prescription Required)AntimalarialsCode: 956

Mefloquine Hydrochloride Tablets 250mg

Generic Formulation:Mefloquine Hydrochloride Tablets IP 250mg
Pack Size:4's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹106.88
Brand Estimate*
₹196.37
Estimated Savings:₹89.49 (46% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Mefloquine Hydrochloride Tablets 250mg is a targeted anti-infective pharmaceutical formulation indicated for the treatment and prophylaxis of susceptible bacterial, fungal, protozoal, or viral infections. It exerts evidence-based therapeutic action by disrupting microbial cellular processes, inhibiting structural synthesis, or neutralizing infectious pathogens.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 956.Report inaccuracy

Usage Guidelines

Take orally with a full glass of water at scheduled intervals as prescribed. Complete the full prescribed course even if symptoms improve early to prevent the development of antimicrobial resistance.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Nausea, mild abdominal discomfort, diarrhea, headache, or dizziness. Rare/Severe: Severe hypersensitivity reactions, Clostridioides difficile-associated colitis, hepatic/renal impairment, and hematologic abnormalities.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Prescription drug. Contraindicated in individuals with documented hypersensitivity to active or related drug substances. Exercise caution in patients with hepatic or renal impairment. Consult physician if pregnant or breastfeeding.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.